Review of Antihypertensive Clinical Trials
Author Information
Author(s): Bhaswat S. Chakraborty
Primary Institution: Cadila Pharmaceuticals, Ahmedabad, Gujarat, India
Hypothesis
What are the critical issues in the control and design of antihypertension clinical trials?
Conclusion
The study highlights the importance of ethical considerations and proper design in antihypertensive clinical trials to ensure valid results.
Supporting Evidence
- The prevalence of hypertension varies globally, with significant implications for clinical trials.
- Ethical considerations are crucial when designing placebo-controlled trials for hypertensive patients.
- Active-control trials are suitable for all randomized subsets of patients, including those with comorbidities.
Takeaway
This paper talks about how to properly design studies that test blood pressure medications, making sure they are safe and effective for patients.
Methodology
The paper reviews international guidelines and current clinical practices regarding antihypertensive trials.
Potential Biases
Potential biases in trial design and patient selection could affect the outcomes.
Limitations
The review may not cover all recent trials or emerging methodologies in antihypertensive research.
Participant Demographics
The review discusses the inclusion of diverse populations, including different ethnicities and age groups.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website